Institutional members access full text with Ovid®

Share this article on:

The Therapeutic Potential of Atorvastatin in a Mouse Model of Postoperative Cognitive Decline

Vizcaychipi, Marcela P. MD, PhD*; Watts, Helena R. PhD*; O'Dea, Kieran P. PhD*; Lloyd, Dafydd G. MBchB*; Penn, Jack W. MBBS*; Wan, Yanjie MD; Pac-Soo, Chen MD*,‡; Takata, Masao MD, PhD*; Ma, Daqing MD, PhD*,§

doi: 10.1097/SLA.0000000000000257
Original Articles

Objective: Postoperative cognitive decline is emerging as a significant complication of surgery among older adults. Animal models indicate a central role of hippocampal inflammatory responses in the pathophysiology of postoperative cognitive decline. We hypothesized that atorvastatin, shown to exert neuroprotective potential in central nervous system (CNS) disorders, would attenuate neuroinflammation and improve cognitive function in mice after surgery and anesthesia.

Methods: C57BL6 adult mice were pretreated with atorvastatin (250 μg) or vehicle, orally, for 5 days before undergoing unilateral nephrectomy under isoflurane anesthesia. We evaluated behavioral parameters related to cognitive function (fear conditioning and Morris Water Maze) and determined systemic and hippocampal interleukin-1β levels, postoperatively. Endothelial COX-2 expression, gross NF-κB and microglial (IBA1, CD68) activation, synaptic function (synapsin-1, PSD95, COX-2), heme oxygenase-1, and GSK3β were also examined.

Results: Surgery induced a significant reduction in hippocampal-dependent fear response that was attenuated by treatment with atorvastatin, which also preserved spatial memory on day 7 after surgery. Atorvastatin evoked significant protection from hippocampal interleukin-1β production, but not systemic interleukin-1β production, accompanied by a marked reduction in hippocampal endothelial COX-2, NF-κB activation and decreased microglial reactivity. Surgery triggered an acute decline in synapsin-1, paralleled by an increase in postsynaptic COX-2 that was partially attenuated by atorvastatin. Furthermore, phosphorylation and inactivation of neuronal GSK3β was significantly enhanced after atorvastatin treatment.

Conclusions: These findings indicate that cognitive decline is very likely associated with synaptic pathology after systemic and central inflammation induced by peripheral surgery/isoflurane anesthesia and suggest that the anti-inflammatory and neuroprotective properties of atorvastatin provide a rationale for its use as a therapeutic strategy for postoperative cognitive decline.

Atorvastatin attenuates neuroinflammation and improves cognitive function in mice after surgery in a model of postoperative cognitive dysfunction (POCD). The data reported here indicate that the anti-inflammatory and neuroprotective properties of atorvastatin provide a rationale for its use as a therapeutic strategy for POCD.

*Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, Chelsea and Westminster Hospital, London, United Kingdom

Department of Pain Management, Gongli Hospital, Pudong, China

Department of Anaesthetics, Wycombe Hospital, Buckinghamshire Hospitals NHS Trust, High Wycombe, Buckinghamshire, United Kingdom

§Department of Anesthesiology, Hubei University of Medicine, Hubei, China.

Reprints: Daqing Ma, MD, PhD, Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea & Westminster Hospital, 369 Fulham Rd, London SW10 9NH, United Kingdom. E-mail: d.ma@imperial.ac.uk.

Disclosure: Supported by a grant from the Alzheimer's Society-BUPA foundation and a grant from the Westminster Medical School and Chelsea and Westminster NHS Trust Joint Research Committee. Authors declare no conflict of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.annalsofsurgery.com).

© 2014 by Lippincott Williams & Wilkins.